Repligen Corporation, a life sciences company focused on bioprocessing technology, has entered into an agreement to acquire Albany, NY-based Engineered Molding Technology (EMT), an innovator and manufacturer of single-use silicone assemblies and components used in the manufacturing of biologic drugs. EMT’s standard and custom molded and over-molded connectors and silicone tubing products are key components in single-use filtration and chromatography systems.   “The acquisition of EMT expands our...